Expertise in
30
conditions

Dr. Charles L. Ludivico

Rheumatology
East Penn. Rheumatology Associates PC
701 Ostrum St Ste 302, 
Fountain Hill, PA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
30
conditions
East Penn. Rheumatology Associates PC
701 Ostrum St Ste 302, 
Fountain Hill, PA 

Overview

Charles Ludivico is a Rheumatologist practicing medicine in Fountain Hill, Pennsylvania.

Dr. Ludivico is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Reactive Arthritis, Sjogren Syndrome, and Rhizomelic Pseudopolyarthritis.

He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 7 clinical trials. Dr. Ludivico is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in PA

Hospital Affiliations

Lehigh Valley Hospital - Pocono
St Luke's Hospital - Monroe Campus
St Luke's Hospital - Upper Bucks Campus
Lehigh Valley Hospital
St Lukes Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

East Penn. Rheumatology Associates PC
701 Ostrum St Ste 302, Fountain Hill, PA 18015

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 21, 2026
Intervention Type: Diagnostic test
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Completed
Publish Date: November 21, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

4 Total Publications

Baricitinib in Patients with Refractory Rheumatoid Arthritis.
Baricitinib in Patients with Refractory Rheumatoid Arthritis.
Journal: The New England journal of medicine
Published: March 31, 2016
Similar Doctors
Expertise in
23
conditions
Dr. Peter A. Merkel
Rheumatology
Expertise in
23
conditions
Dr. Peter A. Merkel
Rheumatology
Referral required

Penn Rheumatology Perelman

3400 Civic Center Boulevard, South Pavilion, 1st Floor, 
Philadelphia, PA 
 (45.1 miles away)
215-662-2454
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Peter Merkel is a Rheumatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Merkel is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy. Dr. Merkel is board certified in Rheumatology, 1994.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required
Before you request

University Of Pennsylvania

3400 Civic Center Blvd, 
Philadelphia, PA 
 (45.0 miles away)
215-662-7278
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Antoine Sreih is a Rheumatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Sreih is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, and Takayasu Arteritis. Dr. Sreih is currently accepting new patients.

Expertise in
13
conditions
Dr. Rennie L. Rhee
Rheumatology
Expertise in
13
conditions
Dr. Rennie L. Rhee
Rheumatology
Referral may be required

Penn Rheumatology Perelman

3400 Civic Center Boulevard, South Pavilion, 1st Floor, 
Philadelphia, PA 
 (45.1 miles away)
215-662-2454
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rennie Rhee is a Rheumatologist practicing medicine in Philadelphia, Pennsylvania. Dr. Rhee is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Granulomatosis with Polyangiitis, Vasculitis, Temporal Arteritis, Giant Cell Arteritis (GCA), and Tissue Biopsy. Dr. Rhee is board certified in Rheumatology, 2014.

Frequently Asked Questions about Dr. Charles L. Ludivico

How do I make an appointment with Dr. Charles L. Ludivico?

You can book an appointment with Dr. Charles L. Ludivico by calling their office at 610-868-1336. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Charles L. Ludivico a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Charles L. Ludivico is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Charles L. Ludivico specialize in?

While Dr. Charles L. Ludivico is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Reactive Arthritis, and Sjogren Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Charles L. Ludivico participate in research or clinical trials?

Yes. Dr. Charles L. Ludivico has published 4 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Dr. Charles L. Ludivico's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Charles L. Ludivico accept my insurance?

Dr. Charles L. Ludivico accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 610-868-1336 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ludivico's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 23 Advanced Conditions
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile